Montana receives COVID-19 medications
Hey savvy news reader! Thanks for choosing local.
You are now reading
1 of 3 free articles.
News from the Office of Steve Daines
Montana will be receiving its second shipment of Regeneron’s antibody therapeutic, casirivimab and imdevimab, which has received emergency use authorization by the Food and Drug Administration. Regeneron’s antibody cocktail is authorized for the treatment of non-hospitalized mild to moderate COVID-19 cases in adults and children 12 years and older who are at high risk for progressing to severe COVID-19 and/or hospitalization.